Sign in

CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company

Foghorn Therapeutics Inc.

Sign in to watch
Ticker
FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-586-3100
Business address
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Regulation FD disclosure
  5. 4 Option exercise Chief Scientific Officer acquired 4,392 shares (option exercise)
  6. 8-K Event Regulation FD disclosure · Other events
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations · Regulation FD disclosure
  9. DEFA14A Proxy Proxy Materials
  10. DEF 14A Proxy Proxy Statement
  11. EFFECT Other Notice of Effectiveness
  12. 8-K Event Material agreement
  13. 424B5 Offering Prospectus
  14. POS AM Other Post-effective Amendment for Registration Statement
  15. EFFECT Other Notice of Effectiveness
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 3 Insider Initial Statement of Ownership
  20. UPLOAD Other SEC-generated Letter

Page 13 of 18 · 356 filings